# Collaborative Risk-stratified Investigation in Thrombosis-prone Inpatients With Critical Illness: Anticoagulation With LMWH in Teens for ThromboProphylaxis (CRITICAL-Teens-TP).

> **NCT06628778** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Johns Hopkins All Children's Hospital** · enrollment: 802 (estimated)

## Conditions studied

- Venous Thromboembolism (VTE)

## Interventions

- **DRUG:** Enoxaparin

## Key facts

- **NCT ID:** NCT06628778
- **Lead sponsor:** Johns Hopkins All Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-04-15
- **Primary completion:** 2034-04-15
- **Final completion:** 2035-04-15
- **Target enrollment:** 802 (ESTIMATED)
- **Last updated:** 2026-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06628778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06628778, "Collaborative Risk-stratified Investigation in Thrombosis-prone Inpatients With Critical Illness: Anticoagulation With LMWH in Teens for ThromboProphylaxis (CRITICAL-Teens-TP).". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06628778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*